CD14 and liver dysplastic nodule: Our findings demonstrate that the elevated MFI of HLA-DR on CD14+ and CD14+ CD16− monocyte is associated with DN and is significantly associated with worsened renal function, highlighting monocyte HLA-DR as a key immune mediator in DN progression and a promising therapeutic target for intervention.